Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Fraser

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|February 18, 2016
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapyHelen Creedon, Laura Gómez-Cuadrado, Žygimantė Tarnauskaitė, et al.
Journal of Medicinal Chemistry|April 27, 2016
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL KinaseCraig Fraser, John C Dawson, Reece Dowling, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|February 18, 2016
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapyHelen Creedon, Laura Gómez-Cuadrado, Žygimantė Tarnauskaitė, et al.
Journal of Medicinal Chemistry|April 27, 2016
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL KinaseCraig Fraser, John C Dawson, Reece Dowling, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Pageof 2